Concept for the provision of an infrastructure for the cross-sectoral, data protection-compliant Secondary Use of Data for Research and Science

Recruiting

• Conditions: all inflammatory rheumatic diseases; M06; M05; M32; M45; Other rheumatoid arthritis; Seropositive rheumatoid arthritis; Systemic lupus erythematosus; Ankylosing spondylitis

• Registration Number: DRKS00032801
• Lead Sponsor: niversitätsklinikum Düsseldorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-11-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Established or first diagnosed disease of the rheumatic type or clarification examination in the case of a suspected disease of the rheumatic type
- Sufficient knowledge of German
- Ability to give consent
- Signed declaration of consent for data transfer and data use in the Data Nexus application.
- Signed written consent for the processing of the evaluation data
- If the patients have already stored biomaterials in the RHINEVIT biobank or if the patients also consent to the donation of biomaterials to the RHINEVIT biobank separately to the Data Nexus consent on the consent day for their participation in Data Nexus: Presence of a consent form for the RHINEVIT biobank and presence of biomaterials and associated annotation data.
- Lack of consent for the RHINEVIT biobank is not an exclusion criterion for participation in Data Nexus.

Exclusion Criteria

- Age < 18 years
- Lack of German language skills
- Lack of capacity to consent
- Presence of a guardian

Study & Design

• Study Type: observational
• Study Design: Not specified